Renaissance Capital logo

Livongo Health Priced, Nasdaq: LVGO

Provides a chronic condition management platform to self-insured employers.

Industry: Health Care

First Day Return: +36.1%

Industry: Health Care

Our mission is to empower people with chronic conditions to live better and healthier lives. We aim to create new, consumer-first experiences that are both personalized and empowering. Livongo is pioneering a new category in healthcare, called Applied Health Signals, which is transforming the management of chronic conditions. We started with diabetes. Many people with diabetes are asked to check their blood glucose regularly, and while they gather this information, they don’t have any context to interpret the data and receive minimal guidance, counseling, or affirmation of how they are doing. With Livongo for Diabetes, members receive a smart, cellular-connected meter, automatically-delivered testing materials, real-time coaching, and monitoring 24 hours a day, seven days a week, 365 days a year. When they track their blood glucose, they receive a highly personalized message about what to do that very moment, which we call a Health Nudge. Today, we have created a unified platform that provides smart, cellular-connected devices, supplies, informed coaching, data science-enabled insights and facilitates access to medications to help our members live better and healthier lives.
more less
IPO Data
IPO File Date 06/28/2019
Offer Price $28.00
Price Range $24.00 - $26.00
Offer Shares (mm) 12.7
Deal Size ($mm) $355
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 07/24/2019
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $355
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters Mountain View, CA, United States
Founded 2014
Employees at IPO 471
Website www.livongo.com

Livongo Health (LVGO) Performance